AGP Picks
View all

Military Industry Today
Provided by AGP

Military Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Military Industry Today.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 14, 2026

Purple Heart Veteran Takes Mission to Help America’s Veterans to Historic UFC Freedom 250 at the White House
Jun. 14, 2026

Purple Heart Veteran Takes Mission to Help America’s Veterans to Historic UFC Freedom 250 at the White House

Indeterminate EIN Presswire
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
Jun. 14, 2026

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026

Indeterminate GlobeNewswire
Rentomojo's Bed and Mattress Rentals Rise in Bangalore in 2026 as Renters Reject ₹50,000 Upfront Costs and Weak Resale Probability for ₹1,000/Month Rentomojo Plans
Jun. 14, 2026

Rentomojo's Bed and Mattress Rentals Rise in Bangalore in 2026 as Renters Reject ₹50,000 Upfront Costs and Weak Resale Probability for ₹1,000/Month Rentomojo Plans

Indeterminate GlobeNewswire
Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
Jun. 14, 2026

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control

Indeterminate GlobeNewswire
Over 100 Organizations Thank America’s Blood Donors on World Blood Donor Day
Jun. 14, 2026

Over 100 Organizations Thank America’s Blood Donors on World Blood Donor Day

Indeterminate GlobeNewswire
Ruvi AI (RUVI) Announces Phase 3 Has Reached 90% Sellout as Investors Race to Secure Remaining Tokens at $0.02
Jun. 14, 2026

Ruvi AI (RUVI) Announces Phase 3 Has Reached 90% Sellout as Investors Race to Secure Remaining Tokens at $0.02

Indeterminate GlobeNewswire
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
Jun. 14, 2026

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire
Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
Jun. 14, 2026

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire
KFSH Highlights Human-Centered AI as a Path to Better Care at HLTH Europe 2026
Jun. 14, 2026

KFSH Highlights Human-Centered AI as a Path to Better Care at HLTH Europe 2026

Indeterminate GlobeNewswire
Das KFSH stellt auf der HLTH Europe 2026 menschenzentrierte KI als Weg zu einer besseren Versorgung in den Mittelpunkt
Jun. 14, 2026

Das KFSH stellt auf der HLTH Europe 2026 menschenzentrierte KI als Weg zu einer besseren Versorgung in den Mittelpunkt

Indeterminate GlobeNewswire
ICE Box Claims Evaluated: Personal Document Storage System for Organization & Secure Protection in Case of Emergencies
Jun. 14, 2026

ICE Box Claims Evaluated: Personal Document Storage System for Organization & Secure Protection in Case of Emergencies

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Military Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.